Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trinity buys Selfcare subsidiary:

This article was originally published in Clinica

Executive Summary

Trinity Biotech is to acquire the infectious diseases testing business of Cambridge Diagnostics Ireland, a subsidiary of Waltham, Massachusetts-based Selfcare. Trinity is paying for the deal with around 500,000 shares in Selfcare (which it owned) plus $280,000 in cash. Cambridge had revenue last year of $3.2 million. Its products include three tests for HIV antibodies. Capillus HIV and RTD HIV are rapid doctors' office-based tests, while Recombigen is a microtitre test for laboratories and blood tests.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts